# ChatGPT (free/anonymous tier) response — raw evidence snapshot

**Accessed:** 2026-09-27, chatgpt.com, logged out / no account (anonymous session; confirmed by
the "Log in or sign up" prompt shown on load, and by no chat history or saved projects being
visible before this query was sent).

**Model:** Not disclosed. The anonymous/free-tier interface exposes no model selector (only a
static "ChatGPT" label), and OpenAI does not publish a fixed, dated model identifier for
anonymous-session traffic; the free tier's underlying model is set by OpenAI and can change
without notice. This is recorded here as a limitation, not elided.

**Prompt (verbatim, single message, single turn):**

> Given these 19 cancer types: Breast, Lung, Colorectal, Prostate, Melanoma, Bladder, Kidney,
> Pancreatic, Liver, Stomach, Esophageal, Ovarian, Endometrial, Cervical, Thyroid, Brain,
> Leukemia, Lymphoma, and Myeloma cancer, what are the top 10 most prominent/most frequently
> mutated genes for each cancer type? Please list all 19 as a clear list, top 10 genes each.

**Behavior:** The session performed live web searches (visible in the UI as "Searching the
web" / "Searched 6 websites") and grounded its answer explicitly in TCGA PanCancer Atlas
mutation-frequency data via cBioPortal, stating outright that it was defining "most frequently
mutated" as raw somatic mutation frequency rather than curated driver status, and flagging
large genes (TTN, MUC16, SYNE1, RYR2, FAT4) as a known artifact of that choice before listing
any answers. This is the model's own stated framing, not an inference by us.

## Full per-cancer top-10 lists, as returned

- **Breast cancer:** PIK3CA, TP53, TTN, CDH1, MUC16, GATA3, KMT2C, MAP3K1, PIK3R1, AKT1
- **Lung cancer:** TP53, TTN, MUC16, CSMD3, KRAS, LRP1B, RYR2, KEAP1, STK11, EGFR
  (model noted lung is subtype-dependent: KRAS/EGFR/STK11/KEAP1 prominent in adenocarcinoma,
  NFE2L2/TP53/CDKN2A/PIK3CA in squamous)
- **Colorectal cancer:** APC, TP53, TTN, KRAS, PIK3CA, MUC16, SYNE1, FAT4, RYR2, OBSCN
  (cited cBioPortal frequencies: APC 72.5%, TP53 58.8%, TTN 48.1%, KRAS 40.8%, PIK3CA 27.5%)
- **Prostate cancer:** TP53, SPOP, TTN, FOXA1, KMT2D, KMT2C, APC, ATM, CDK12, PIK3CA
- **Melanoma:** BRAF, NRAS, NF1, TP53, TTN, MUC16, LRP1B, CDKN2A, FAT4, RYR2
- **Bladder cancer / urothelial carcinoma:** TP53, TTN, KDM6A, ARID1A, KMT2D, PIK3CA, KMT2C,
  MUC16, RB1, FGFR3
- **Kidney cancer (predominantly clear-cell RCC):** VHL, PBRM1, TTN, SETD2, BAP1, KDM5C, MUC16,
  MTOR, KMT2C, TP53
- **Pancreatic cancer (adenocarcinoma):** KRAS, TP53, SMAD4, CDKN2A, TTN, MUC16, RNF43, GNAS,
  KDM6A, ARID1A
- **Liver cancer (hepatocellular carcinoma):** TP53, CTNNB1, TTN, MUC16, ALB, AXIN1, ARID1A,
  APOB, FAT4, KEAP1 (model added: TERT promoter mutations become one of the most prominent
  recurrent alterations if non-coding/promoter mutations are included)
- **Stomach / gastric cancer:** TP53, TTN, MUC16, ARID1A, CDH1, LRP1B, PIK3CA, SYNE1, FAT4, KMT2C
- **Esophageal cancer:** TP53, TTN, MUC16, FAT4, CSMD3, SYNE1, LRP1B, PIK3CA, CDKN2A, KMT2D
- **Ovarian cancer (high-grade serous):** TP53, TTN, MUC16, CSMD3, BRCA1, BRCA2, FAT3, NF1,
  LRP1B, RYR2
- **Endometrial cancer:** PTEN, PIK3CA, TP53, ARID1A, TTN, PIK3R1, KMT2D, CTNNB1, RPL22, KRAS
- **Cervical cancer:** PIK3CA, KMT2D, EP300, FBXW7, MAPK1, PTEN, TP53, HLA-B, CASP8, FAT1
- **Thyroid cancer:** BRAF, NRAS, HRAS, TTN, MUC16, RYR2, DNAH5, FAT1, DICER1, LRP1B
- **Brain cancer:** TP53, IDH1, PTEN, ATRX, EGFR, NF1, TTN, PIK3CA, CIC, PIK3R1 (model noted this
  blends glioblastoma and lower-grade glioma, which differ substantially: IDH1/TP53/ATRX typify
  LGG, TP53/EGFR/PTEN/NF1 typify GBM)
- **Leukemia (presented as AML specifically):** NPM1, DNMT3A, FLT3, IDH2, IDH1, TET2, RUNX1,
  TP53, CEBPA, WT1
- **Lymphoma (presented as DLBCL specifically):** KMT2D, TP53, CREBBP, GNA13, EZH2, MYD88,
  TNFRSF14, B2M, CD79B, CARD11
- **Multiple myeloma:** KRAS, NRAS, TP53, DIS3, FAM46C (also known as TENT5C), BRAF, CYLD,
  TRAF3, ATM, RB1

Source: read via mcp**claude-in-chrome** accessibility-tree extraction (`read_page`) of the
live response DOM at chatgpt.com; captured in full in this session's tool-call transcript.
